BARBIERI, Elena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.571
EU - Europa 1.660
AS - Asia 459
SA - Sud America 9
OC - Oceania 8
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.717
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.564
GB - Regno Unito 395
IT - Italia 365
IE - Irlanda 345
CN - Cina 176
SE - Svezia 165
DE - Germania 148
HK - Hong Kong 103
UA - Ucraina 96
SG - Singapore 55
FI - Finlandia 47
TR - Turchia 39
BG - Bulgaria 33
VN - Vietnam 22
FR - Francia 21
IN - India 19
IR - Iran 17
ID - Indonesia 11
RU - Federazione Russa 8
AU - Australia 6
BE - Belgio 5
CA - Canada 5
MT - Malta 5
BR - Brasile 4
MY - Malesia 4
NG - Nigeria 4
ES - Italia 3
EU - Europa 3
JP - Giappone 3
LT - Lituania 3
PL - Polonia 3
TW - Taiwan 3
AL - Albania 2
AT - Austria 2
BO - Bolivia 2
CH - Svizzera 2
CL - Cile 2
DK - Danimarca 2
EG - Egitto 2
IQ - Iraq 2
MX - Messico 2
NL - Olanda 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
AM - Armenia 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
HU - Ungheria 1
KE - Kenya 1
KR - Corea 1
LB - Libano 1
ME - Montenegro 1
MK - Macedonia 1
NO - Norvegia 1
PK - Pakistan 1
PT - Portogallo 1
UZ - Uzbekistan 1
Totale 4.717
Salva come PNG Salva come JPEG
Città #
Dublin 345
Fairfield 322
Southend 298
Chandler 265
Woodbridge 224
Ashburn 197
Houston 180
Jacksonville 174
Dearborn 168
Ann Arbor 162
Nyköping 131
Seattle 116
Cambridge 107
Wilmington 106
Hong Kong 101
Beijing 68
Modena 49
Singapore 45
Princeton 37
New York 34
Sofia 33
Eugene 32
Izmir 29
Helsinki 27
San Diego 25
Bremen 24
Dong Ket 22
Shanghai 20
Rome 18
Fremont 16
Redwood City 14
Milan 13
Jakarta 11
Bologna 10
Catania 10
London 10
Norwalk 9
Des Moines 7
Falls Church 7
Los Angeles 7
Palermo 7
San Mateo 7
Hefei 6
Nanjing 6
Padova 6
Monmouth Junction 5
Pisa 5
Bari 4
Boardman 4
Brescia 4
Brussels 4
Lagos 4
Sassari 4
Bangalore 3
Cagliari 3
Dallas 3
Genoa 3
Guarene 3
Martano 3
Nanchang 3
New Bedfont 3
Ottawa 3
Phoenix 3
Prescot 3
Rabat 3
Reggio Emilia 3
Shenyang 3
Taipei 3
Verona 3
Wandsworth 3
Acton 2
Albignasego 2
Amsterdam 2
Arcore 2
Ardabil 2
Arezzo 2
Augusta 2
Avellino 2
Bagnoli del Trigno 2
Berlin 2
Bra 2
Calcinaia 2
Canberra 2
Cesena 2
Chengdu 2
Chicago 2
Civita Castellana 2
Forlì 2
Formigine 2
Fulham 2
Ginosa 2
Hebei 2
Ivrea 2
Kunming 2
La Paz 2
Lamezia Terme 2
Marudo 2
Melita 2
Messina 2
Mexico 2
Totale 3.650
Salva come PNG Salva come JPEG
Nome #
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVO 296
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 281
Magnetic Resonance Imaging and Ultrasonography in Predicting Infiltrating Residual Disease after Preoperative Chemotherapy in Stage II-III Breast Cancer 209
Primary pulmonary cancer colliding with metastatic breast carcinoma: hitherto unreported cases of cancer-to-cancer metastasis focusing on clinical implications 208
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 193
Achievements and unmet needs in the management of advanced ovarian cancer 185
Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis 183
Timing for starting second line therapy in recurrent ovarian cancer. 179
Use of Recombinant Factor IX and Thromboelastography in a Patient With Hemophilia B Undergoing Liver Transplantation: A Case Report 174
Double-blind, placebo-controlled, multicentric randomized phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal HER2-negative, hormone receptor-positive operable breast cancer 174
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis 173
Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer 166
Primary and secondary prevention to effectively reduce the risk of bisphosphonate-related osteonecrosis of the jaw in patients with bone metastases . 157
Ki67 as a Predictor of Response and Long Term Survival in Hormone Receptor Positive/HER2 Negative Breast Cancer Patients Treated with Preoperative Chemotherapy 150
Posterior reversible encephalopathy syndrome during ipilimumab therapy for malignant melanoma 147
Biomarkers predicting clinical benefit: fact or fiction? 144
Prognostic impact of estrogen receptor (ER) level changes during progression for patients with both ER-positive (ER+) primary breast cancer and paired recurrence 142
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 127
Change in HER2 Status in HER2 Positive Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without Anti-HER2 Therapy: Analysis of Two Consecutive Cohorts 126
PREVALENCE OF NODE NEGATIVE AND SMALL SIZE TUMORS IN A NATIONAL, RANDOMISED, PHASE III ADJUVANT TRIAL IN HER2 + EARLY BREAST CANCER (SHORT-HER STUDY) 125
Discordant HER2 Total and HER2 Homodimer Levels by HERmark Analysis in Matched Primary and Metastatic Breast Cancer FFPE Specimens. 121
Tumori ginecologici 116
Prognostic role of HER2 loss after neoadjuvant therapy in patients with HER2-positive operable breast cancer 107
P53 EXPRESSION IS A SIGNIFICANT PREDICTOR OF RESPONSE AND PROGNOSIS IN STAGE II-III BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY 102
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVE: ANALISI PRELIMINARE DELLE TOSSICITA’ 102
COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS 101
35. PREDICTORS OF HER2 FISH POSITIVITY IN PRIMARY BREAST CANCER DIAGNOSIS SCORED 2+ WITH IHC: RESULTS OF A SINGLE INSTITUTION ANALYSIS 99
VALUTAZIONE DEL RISCHIO DI TOSSICITA’ CARDIACA DI TRASTUZUMAB IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO IN TRATTAMENTO ADIUVANTE 94
KI67 AS A PREDICTOR OF RESPONSE AND LONG TERM SURVIVAL IN HORMONE RECEPTOR POSITIVE/HER2 NEGATIVE BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY 87
Quantitative HER2 measurement and PI3K mutation profile in matched primary and metastatic breast cancer tissues. 87
ACHIEVEMENTS AND UNMET NEEDS IN THE MANAGEMENT OF EPITHELIAL OVARIAN CANCER 84
Automated capture-based NGS workflow: one thousand patients experience in a clinical routine framework 70
PREDICTIVE AND PROGNOSTIC ROLE OF P53 EXPRESSION IN STAGE II-III BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY: A SINGLE INSTITUTION ANALYSIS 46
Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World Setting 26
Totale 4.781
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.175
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.175
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020850 0 0 44 67 115 140 187 82 86 32 65 32
2020/2021664 81 33 54 45 77 58 52 72 45 54 57 36
2021/2022539 9 86 57 12 11 23 27 13 64 45 121 71
2022/20231.047 97 98 58 76 71 103 13 62 403 11 29 26
2023/2024559 24 21 40 39 71 46 49 118 21 27 44 59
2024/202570 17 41 12 0 0 0 0 0 0 0 0 0
Totale 4.781